BRD4 and neoplasm: JQ1 decreased PD-L1 expression through BRD4-dependent occupancy of the CD274 promoter, thereby increasing tumor-associated CD8+ T cells producing IFN-γ and granzyme B in lymphoma, prostate, and oral squamous cell carcinoma models (140–142).